Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Peripheral T-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02464228
What this trial is testing

Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

Who this might be right for
Relapsed or Refractory Peripheral T-Cell Lymphoma
Kura Oncology, Inc. 65
Testing effectiveness (Phase 2)UnknownNCT04470141
What this trial is testing

SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Nanjing Sanhome Pharmaceutical, Co., Ltd. 130
Large-scale testing (Phase 3)Study completedNCT03593018
What this trial is testing

Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL

Who this might be right for
Relapsed Angioimmunoblastic T-Cell LymphomaRefractory Angioimmunoblastic T-cell Lymphoma
The Lymphoma Academic Research Organisation 86
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Testing effectiveness (Phase 2)UnknownNCT02495415
What this trial is testing

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T-cell Lymphoma
CerRx, Inc. 140
Early research (Phase 1)UnknownNCT04162340
What this trial is testing

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Who this might be right for
T Cell Lymphoma in RelapseRefractory T-Cell Lymphoma
iCell Gene Therapeutics 12
Early research (Phase 1)Study completedNCT00962507
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 11
Testing effectiveness (Phase 2)UnknownNCT03630731
What this trial is testing

Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117305
What this trial is testing

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
CD7+ LymphomaT Cell Lymphoma
Zhengzhou University 38
Large-scale testing (Phase 3)WithdrawnNCT03355768
What this trial is testing

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Jennifer Amengual
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535710
What this trial is testing

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma, RelapsedSezary Syndrome+1 more
Shanghai Jiao Tong University School of Medicine 37
Testing effectiveness (Phase 2)Study completedNCT02106650
What this trial is testing

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Who this might be right for
Relapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma
Acrotech Biopharma Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT03552692
What this trial is testing

Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma

Who this might be right for
T-Cell Lymphoma RelapsedT-Cell Lymphoma Refractory
Fondazione Italiana Linfomi - ETS 22
Very early researchStudy completedNCT01913119
What this trial is testing

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

Who this might be right for
Histologically Proven Extranodal NKTcell Lymphoma
Samsung Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00005950
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+7 more
National Cancer Institute (NCI) 111
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Study completedNCT05269940
What this trial is testing

Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies

Who this might be right for
Non Hodgkin LymphomaPeripheral T Cell LymphomaCLL/SLL
Nanjing Zenshine Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Next Page